Intensity Therapeutics INTS
NASDAQ INTS
$3.27 -0.01 (-0.37%)
As of: Oct 21, 2026 · 12:09 PM EDT

Intensity Therapeutics (INTS) Short-term Investments (2023 - 2024)

Updated

Intensity Therapeutics (INTS) recorded Short-term Investments of $3.1 million in Q2 2024, up 2.0% from the prior quarter.

Analysis

Intensity Therapeutics (INTS) Short-term Investments (2023 - 2024) Analysis & Trends

At the end of FY2023, Intensity Therapeutics reported Short-term Investments of $6.22 million.

  • Quarterly Short-term Investments has ranged from $3.04 million in Q1 2024 to $8.96 million in Q3 2023 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $3.04 million (Q1 2024), $6.22 million (Q4 2023) and $8.96 million (Q3 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,132.21 Bn 1,100.80 Bn 19.71 Bn
2 Johnson & Johnson 616.27 Bn 534.80 Bn 17.26 Bn
3 AbbVie 500.10 Bn 473.21 Bn 12.70 Bn
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn
6 Astrazeneca 261.53 Bn 235.22 Bn 12.86 Bn
7 Amgen 234.99 Bn 190.39 Bn 7.24 Bn
8 Gilead Sciences 190.14 Bn 164.34 Bn 6.22 Bn
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn
10 Intensity Therapeutics 8.85 Mn -29.92 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 3.10 Mn
Mar 31, 2024 3.04 Mn
Dec 31, 2023 6.22 Mn
Sep 30, 2023 8.96 Mn
API Access

Intensity Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=INTS&period=max&api_key=YOUR_API_KEY